Patents by Inventor Paresh Vyas

Paresh Vyas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220267853
    Abstract: The present invention is directed to leukaemic stem cells, in particular methods for detecting leukaemic stem cells, use of said leukaemic stem cells in the diagnosis of myeloid leukaemia, methods of treatment, and associated kits and compositions.
    Type: Application
    Filed: November 30, 2018
    Publication date: August 25, 2022
    Inventors: Paresh Vyas, Zahra Aboukhalil, Bilyana Stoilova, Dimitris Karamitros
  • Patent number: 10191055
    Abstract: The present invention relates to diagnostic screens, gene expression profiles, methods and kits for detection of acute myeloid leukaemia leukaemic stem cells. Diagnostic and prognostic methods based on said diagnostic screens and/or gene expression profiles also form part of the invention.
    Type: Grant
    Filed: November 6, 2015
    Date of Patent: January 29, 2019
    Assignee: OXFORD UNIVERSITY INNOVATION LIMITED
    Inventors: Paresh Vyas, Lynn Quek
  • Publication number: 20180299427
    Abstract: The present invention relates to diagnostic screens, antibodies, methods and kits for detection/prognosis of acute myeloid leukaemia. The diagnostic screen detects the presence (+) or absence (?) of the cell surface polypeptide markers i) CD34+; ii) CD45RA+; and iii) CD90? and/or CD123+. Antibodies specific for one or more of said cell surface polypeptide markers may be used in the diagnostic screen of the invention. Diagnostic and prognostic methods for detecting and monitoring minimal residual disease based on said screen also form part of the invention.
    Type: Application
    Filed: December 14, 2017
    Publication date: October 18, 2018
    Inventors: Paresh Vyas, Nicolas Goardon, Sylvie Freeman
  • Publication number: 20160146821
    Abstract: The present invention relates to diagnostic screens, gene expression profiles, methods and kits for detection of acute myeloid leukaemia leukaemic stem cells. Diagnostic and prognostic methods based on said diagnostic screens and/or gene expression profiles also form part of the invention.
    Type: Application
    Filed: November 6, 2015
    Publication date: May 26, 2016
    Inventors: Paresh Vyas, Lynn Quek
  • Publication number: 20130337474
    Abstract: The present invention relates to diagnostic screens, antibodies, methods and kits for detection/prognosis of acute myeloid leukaemia. The diagnostic screen detects the presence (+) or absence (?) of the cell surface polypeptide markers i) CD34+; ii) CD45RA+; and iii) CD90? and/or CD123+. Antibodies specific for one or more of said cell surface polypeptide markers may be used in the diagnostic screen of the invention. Diagnostic and prognostic methods for detecting and monitoring minimal residual disease based on said screen also form part of the invention.
    Type: Application
    Filed: December 21, 2011
    Publication date: December 19, 2013
    Applicant: ISIS INNOVATION LIMITED
    Inventors: Paresh Vyas, Nicolas Goardon, Sylvie Freeman